Vascular Biogenics Ltd (NASDAQ:VBLT)
| 0.1534 Delayed Data As of Dec 02 |  0.00 / 0.00%Today’s Change | 0.11 Today|||52-Week Range 2.35 | -92.21% Year-to-Date |
Latest VBLT News | Press Releases
No recent news for Vascular Biogenics Ltd.
Today’s Trading
| Previous close | 0.15 |
| Today’s open | 0.16 |
| Day’s range | 0.15 - 0.16 |
| Volume | 51,588 |
| Average volume (3 months) | 2,664,838 |
| Market cap | $10.4M |
Data as of 3:38pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | +18.71% |
| Earnings growth (this year) | -15.56% |
| Earnings growth (next 5 years) | +16.00% |
| Revenue growth (last year) | -16.70% |
| P/E ratio | NM |
| Price/Sales | 170.19 |
| Price/Book | 0.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IMNNImunon Inc | +0.08 | +5.71% |
| CALACalithera Bioscience... | -0.05 | -2.48% |
| NDRAENDRA Life Sciences ... | +0.02 | +8.78% |
| HMTXFHemostemix Inc | -0.01 | -7.23% |
Data as of 3:45pm ET, 12/02/2022
Financials
| Next reporting date | March 23, 2023 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $768.0K |
| Annual profit (last year) | -$29.9M |
| Net profit margin | -3,895.83% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Modi’in, Jerusalem |
Forecasts
